RUS / ENG Federal State Unitary Enterprise "State Research Institute of Highly Pure Biopreparations" of the Federal Medical and Biological Agency SRI OChB Science Production Preparations Contacts We develop new directions in the field of biotechnology and use the experience accumulated by generations of Russian scientists for the development and implementation of the newest drugs of the highest quality into medical practice. FSUE "State. SRI OChB "FMBA of Russia is one of the leading biotechnological centers in Russia, which, along with other organizations, occupies a leading position in domestic medical biotechnology. FSUE "State. NII OChB »FMBA of Russia is a diversified research and production complex with a well-developed science-intensive production and highly qualified specialists capable of carrying out a full cycle of work from fundamental research to the creation of industrial technologies for the production of competitive new generation drugs. The Institute conducts a wide range of fundamental and applied research on the creation of highly effective drugs and medical devices of a new generation. Medicines are being developed based on recombinant and natural proteins, synthetic peptides, as well as bacterial therapeutic agents, and new dosage forms are being created. The research and production base is equipped with modern instrumentation and equipment, which allows production and research and development work at a high level, including analytical research, the cultivation of microorganisms and animal cells, the isolation of target components and their chromatographic purification, the development of new technologies for obtaining finished forms of medicinal products. news 07.07.2014 BETALEIKIN IN TREATMENT OF HEPATITIS C, genotype 1 07/02/2014 Dear colleagues! We are glad to inform you that the Jubilee Scientific and Practical Conference MODERN PROBLEMS OF IMMUNOPHARMACOLOGY, BIOTECHNOLOGY AND CYTOKINE REGULATION dedicated to the 40th anniversary of the Federal State Unitary Enterprise "State Research Institute of Highly Pure Biological Products" FMBA of Russia has successfully completed its work. The conference was attended by 250 specialists from the Russian Federation and the CIS countries. During the plenary and breakout sessions, 80 scientific reports on the topics of the conference were presented. The poster session was also successfully held, at which the conference participants got acquainted with 30 scientific works presented in the form of a poster presentation. We hope that the information, exchange of experience, professional contacts and friendly communication were useful to you. You can read the conference materials here View photos 05/10/2014 Conference program Dear colleagues! We invite you to familiarize yourself with the program Anniversary scientific and practical conference "MODERN PROBLEMS OF IMMUNOPHARMACOLOGY, BIOTECHNOLOGY AND CYTOKINE REGULATION" June 25 - 27, 2014, St. Petersburg conference program 04.04.2012 New drugs approved for medical use The following drugs are approved for use: BESTIM® (P N003335 / 03 dated 03.08.2010), REXOD®, LSR-007164 / 09-100909, REXOD®-OF, INTERFERAL®, LSR-007454/10, ANAKINRA. © 2009-2012 State Research Institute of Highly Pure Biological Products of the Federal Medical and Biological Agency. Any reproduction, reprint and other use of the site materials is possible only with the written consent of the site administration. made in Shishki.Design